Why the study?
Does intravenous insulin improve outcomes in a patient with hypertriglyceridemia-induced acute pancreatitis?
Does intravenous insulin improve outcomes in a patient with hypertriglyceridemia-induced acute pancreatitis?
Intravenous insulin can be successfully used as an adjunctive treatment for hypertriglyceridemia-induced acute pancreatitis.
Answers are grounded in this paper and cite their sources.
May support adjunctive intravenous insulin in hypertriglyceridemia-induced pancreatitis; hypothesis-generating case report requiring prospective trials.
Severe hypertriglyceridemia is one of the many yet rare risk factors associated with acute pancreatitis. The level of triglycerides plays a crucial role in determining the method and duration of treatment. As with the treatment of other causes of acute pancreatitis, bowel rest, intravenous fluids, and supportive care play a crucial role. However, depending on the degree of hypertriglyceridemia, the role of other treatment options may need to be implemented. There are no set established guidelines for the management of hypertriglyceridemia-induced pancreatitis, but the role of insulin, heparin, and plasmapheresis has been studied and successfully used in its management. We report the case a 44-year-old female with clinical acute pancreatitis secondary to hypertriglyceridemia who was successfully managed with the addition of intravenous insulin.
No takes yet. Share an insight, caveat, or question.
Khan et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: